Table 1 Clinical characteristics of the patients with osteochondral (OCD) lesions
From: Osteochondral lesions in children with juvenile idiopathic arthritis
Patient | JIA type | Sex, age at diagnosis | Medication | Age at diagnosis of OCD | Number of Ia. injections | OCD location, acc to MRI | Operative treatment |
|---|---|---|---|---|---|---|---|
1 | Extended polyarthritis | M, 4 | MTX Etanercept Infliximab Abatacept | 10 | 12 | Femur | - |
lateral | |||||||
2 | Polyarthritis | F, 10 | MTX | 12 | 3 | Femur lateral | + |
15 | 7 | (dx) | |||||
Femur, | |||||||
lateral (sin) | + | ||||||
3 | Oligoarthritis | M, 12 | MTX | 15 | 4 | Femur lateral | + |
4 | Extended Polyarthritis | M, 5 | MTX | 10 | 9 | Femur lateral (l.a.) | - |
5 | Oligoarthritis | F, 10 | MTX | 13 | 1 | Femur lateral | + |
6 | Polyarthritis | M, 11 | MTX | 12 | 5 | Femur medial and lateral l.a. | - |
7 | Oligoarthritis | F, 2 | MTX | 10 | 2 | Femur medial and lateral | + |
8 | Extended polyarthritis | F, 3 | MTX Oxichlorin Infliximab Adalimumab | 14 | 3 | Femur medial | - |
9 | Polyarthritis | F, 2 | Leflunomide | 11 | 9 | Talus | + |
10 | Extended polyarthritis | F, 2 | MTX, SSZ Leflunomide Etanercept Infliximab | 10 | 12 | Femur medial | - |
11 | Polyarthritis | F, 10 | MTX | 14 | 3 | Femur medial l.a. | + |
12 | Polyarthritis | F, 9 | MTX | 10 | 3 | Femur (dx) medial and lateral | - |
Femur medial (sin) | |||||||
13 | Polyarthritis | F, 4 | MTX Leflunomide Etanercept | 15 | 5 | Femur medial | + |